PROFOUND MEDICAL CORP (PROF)
CA74319B5027 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -31.39M | -28.57M | -28.67M | -30.70M | -21.62M | |||
| Depreciation Amortization | 1.16M | 1.15M | 1.60M | 1.88M | 1.54M | |||
| Income Taxes - Deferred | N/A | 58.00K | N/A | N/A | N/A | |||
| Change In Working Capital | 1.08M | 296.00K | -3.72M | -1.05M | -5.83M | |||
| Interest Paid | N/A | 669.00K | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 160.00K | N/A | N/A | N/A | |||
| Other non cash items | 4.27M | 4.77M | 4.99M | 7.51M | 5.34M | |||
| OPERATING CASH FLOW | -24.83M | -22.30M | -25.80M | -22.36M | -20.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -593.00K | -350.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | -593.00K | -350.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.53M | -1.20M | -356.00K | -386.00K | -9.61M | |||
| Stock Issued/Repurchased | 22.94M | 2.67M | 263.00K | 6.43M | 103.68M | |||
| Other Financing Activity | N/A | 0.00 | 7.12M | -99.00K | -6.64M | |||
| FINANCING CASH FLOW | 18.55M | 1.46M | 7.03M | 5.95M | 87.43M | |||
| Exchange Rate Effect | -226.00K | 529.00K | -1.87M | 244.00K | 2.60M | |||
| CHANGE IN CASH | -6.50M | -20.30M | -20.64M | -16.76M | 69.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.83M | -22.30M | -25.80M | -22.36M | -20.57M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -593.00K | -350.00K | |||
| FREE CASH FLOW | -24.83M | -22.30M | -25.80M | -22.95M | -20.92M | |||
All data in USD